Forward P/S Multiple: researchsolutions.com (RSSS)
Research Solutions is aggressively expanding its presence in med-IT by scaling its Article Galaxy SaaS service. The forward price-to-sales ratio clearly demonstrates the resilience of the business's margins, while 0.70 reflects the most recent value of the metric. Stable demand for scientific data guarantees predictable revenue, with growth driven by the acquisition of niche developers and the expansion of B2B subscriptions.
RSSS (researchsolutions.com): analytical breakdowns and indicator data
- current price and projected stock value:
- company stock exchange capitalization indicators:
- issuer book value statistics:
- debt and solvency information:
Debt to Equity Research Solutions|RSSS - Long-Term Liabilities to Capital|Short-Term Debt to Equity Research Solutions, Inc.|RSSS - Company Debts|Debt to Book Value Research Solutions, Inc.|RSSS - Company Long-Term Debts|Company Current Liabilities Research Solutions|Quick Ratio researchsolutions.com
- net income and valuation multiples indicators:
RSSS - Net Financial Result|Expected Profit Research Solutions|RSSS - Market Cap to Earnings|Future Price to Earnings Research Solutions|RSSS - Growth-Adjusted P/E Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Research Solutions, Inc.|RSSS - Operating income before deduction of amortization|Earnings per share for the last twelve months Research Solutions|RSSS - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months researchsolutions.com|RSSS - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Research Solutions
- company sales and revenue statistics:
Summary company analytics:Research Solutions (RSSS)
This indicator assesses the ratio of market capitalization to projected revenue, allowing for the measurement of the growth premium amid tight monetary policy. By analyzing the forward P/S ratio, an investor determines the asset's degree of overbought status, which is particularly relevant for Research Solutions (RSSS), whose capitalization depends on scaling the automation of scientific data delivery via the Article Galaxy platform.
Competitors of Research Solutions
Forward P/S Multiple VEEV (Veeva)|DOCS - Forward Price-to-Revenue Multiple|HealthEquity Corp - Forward P/S Multiple|Forward Price to Sales WAY (Waystar Corp)|CRVL (CorVel Corporation) - Forward Price-to-Revenue Multiple|priviahealth.com - Forward Price to Sales|Price-to-Projected Revenue Ratio Huron|Certara Inc (CERT) - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio Omnicell Corp (OMCL)|GDRX - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Schrodinger, Inc. SDGR|phreesia.com - Price-to-Projected Revenue Ratio|OMDA: Forward Price-to-Revenue Multiple|EVH - Forward P/S Multiple|HSTM (HealthStream Corp) - Forward Price-to-Revenue Multiple|DH: Price to Expected Revenue Ratio|CCSI (Consensus Cloud Solutions) - Forward P/S Multiple|agilonhealth.com (AGL) - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio Absci Corporation (ABSI)|SY - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio National Research Corporation NRC|SPOK: Market Cap to Projected Revenue|OPRX - Price-to-Projected Revenue Ratio|Market Cap to Expected Sales Ratio trubridge.com TBRG|Simulations Plus (SLP) - Price-to-Projected Revenue Ratio|SOPHiA GENETICS - Forward Price to Sales|Price-to-Projected Revenue Ratio Health Catalyst, Inc|CareCloud Corp (CCLD) - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio DLH Holdings Corp. (DLHC)|Market Cap to Expected Sales Ratio onemednet.com|Price-to-Projected Revenue Ratio Scienture SCNX|Market Cap to Expected Sales Ratio Healthcare Triangle Inc (HCTI)|iSpecimen Corp - Forward P/S Multiple|Market Cap to Expected Sales Ratio Bullfrog AI Holdings BFRG|WORX (SCWorx Corp.) - Forward Price-to-Revenue Multiple|MSPR: Price to Expected Revenue Ratio|Forward Price-to-Revenue Multiple ICCT|MEDS: Forward Price to Sales|Price-to-Projected Revenue Ratio Orgenesis Corp (ORGS)|Forward Price-to-Revenue Multiple r1rcm.com RCM|Forward P/S Multiple SHCR (Sharecare, Inc.)|streamlinehealth.net (STRM) - Market Cap to Future Revenue Ratio|Syra Health - Forward P/S Multiple|AMEH (Apollo Medical Holdings) - Market Cap to Projected Revenue|Model N Corp (MODN) - Price-to-Projected Revenue Ratio|NextGen Healthcare Corp - Forward Price to Sales
